Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs MadeMed

Belle Health
Graded #48

Lower grade

vs+3.4000000000000057
MadeMed
Graded #30

Higher grade

The verdict

MadeMed takes it — 80.4/100 to 77/100.

MadeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publishes its price at every single dose, so what a titrated dose costs is knowable on day one.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBelle Health +18
92
74
Dose & formulationMadeMed +18
72
90
Clinical oversightMadeMed +13
71
84
Labs & monitoringBelle Health +10
72
62
FulfillmentMadeMed +5
85
90
Contract termsMadeMed +33
55
88
Belle Health · left barMadeMed · right bar

The numbers

MetricBelle HealthMadeMed
WeighScore77/10080.4/100
GradeC+B−
Scorecard rank#48#30
Semaglutide$119/mo$239/mo quarterly (from $199/mo on 6 months)
Tirzepatide$199/mo (all doses, 3-month plan, compounded)$399/mo quarterly (from $369/mo on 6 months)
CoverageAll 50 states40 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Belle Health

Graded #48 · C+

Strengths

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

Where it loses points

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
MadeMed

Graded #30 · B−

Strengths

  • One flat price at every dose, published dose by dose — semaglutide 0.25–2.4mg, tirzepatide 2.5–15mg
  • LegitScript verified, with board-certified physician review and US compounding pharmacies
  • Full refund minus a $39 visit fee if you are not prescribed, stated before checkout
  • Oral semaglutide and oral tirzepatide alongside the injections; free overnight shipping with supplies

Where it loses points

  • The most expensive tirzepatide here at $399/mo quarterly
  • 40 states rather than nationwide
  • No published recurring lab programme
  • Ships one vial every two months, a less flexible cadence than a monthly refill

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard